Number needed to harm in the post-marketing safety evaluation: results for rosiglitazone and pioglitazone.

Number needed to harm in the post-marketing safety evaluation: results for rosiglitazone and pioglitazone.

Item
http://www.wikidata.org/entity/Q38587979
The CXCL10/CXCR3 Axis and Cardiac Inflammation: Implications for Immunotherapy to Treat Infectious and Noninfectious Diseases of the HeartThe current role of thiazolidinediones in diabetes management.Number needed to treat (NNT) in clinical literature: an appraisal.Benefit-Risk of Therapies for Relapsing-Remitting Multiple Sclerosis: Testing the Number Needed to Treat to Benefit (NNTB), Number Needed to Treat to Harm (NNTH) and the Likelihood to be Helped or Harmed (LHH): A Systematic Review and Meta-Analysis.Testing the usefulness of the number needed to treat to be harmed (NNTH) in benefit-risk evaluations: case study with medicines withdrawn from the European market due to safety reasons.From the Cover: Three-Dimensional (3D) HepaRG Spheroid Model With Physiologically Relevant Xenobiotic Metabolism Competence and Hepatocyte Functionality for Liver Toxicity Screening.Targeting energy metabolism via the mitochondrial pyruvate carrier as a novel approach to attenuate neurodegeneration.
P2860

Number needed to harm in the post-marketing safety evaluation: results for rosiglitazone and pioglitazone.

Item
http://www.wikidata.org/entity/Q38587979
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Number needed to harm in the p ...... osiglitazone and pioglitazone.
@en
type
label
Number needed to harm in the p ...... osiglitazone and pioglitazone.
@en
prefLabel
Number needed to harm in the p ...... osiglitazone and pioglitazone.
@en
P1433
P1476
P2093
P2860
P304
P31
P356
P433
P478
P50
P577
P698
P356
P1433
P1476
Number needed to harm in the p ...... osiglitazone and pioglitazone.
@en
P2093
P2860
P304
P31
P356
P433
P478
P50
P577
P698